We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-14.8%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$13.1B
AUM Growth
-$2.86B
Cap. Flow
-$262M
Cap. Flow %
-2%
Top 10 Hldgs %
37.9%
Holding
1,479
New
56
Increased
646
Reduced
399
Closed
58

Top Buys

Rank Stock Value
1
MAA icon
Mid-America Apartment Communities
MAA
+$174M
2
EQIX icon
Equinix
EQIX
+$83.3M
3
DLR icon
Digital Realty Trust
DLR
+$82.9M
4
PLD icon
Prologis
PLD
+$52.3M
5
INVH icon
Invitation Homes
INVH
+$39.6M

Top Sells

Rank Stock Value
1
AMT icon
American Tower
AMT
+$263M
2
VICI icon
VICI Properties
VICI
+$230M
3
ESS icon
Essex Property Trust
ESS
+$96.1M
4
VTR icon
Ventas
VTR
+$61.2M
5
EBIZ icon
Global X E-commerce ETF
EBIZ
+$39.2M

Sector Composition

Rank Sector Weight
1 Real Estate 60.75%
2 Technology 8.8%
3 Healthcare 4.18%
4 Consumer Discretionary 3.61%
5 Financials 3.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AFRM icon
1076
PUT
Affirm
AFRM
$24.1B
$20K ﹤0.01%
+1,000
New +$27.2K
IONS icon
1077
Ionis Pharmaceuticals
IONS
$8.99B
$20K ﹤0.01%
528
+116
+28% +$4.37K
ITCI
1078
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$20K ﹤0.01%
352
+75
+27% +$4.25K
MEDP icon
1079
Medpace
MEDP
$16B
$19K ﹤0.01%
125
+20
+19% +$2.9K
TWOU
1080
DELISTED
2U Inc
TWOU
$19K ﹤0.01%
+60
New +$18.5K
ALKS icon
1081
Alkermes
ALKS
$8.39B
$18K ﹤0.01%
609
+137
+29% +$3.94K
APLS
1082
DELISTED
Apellis Pharmaceuticals
APLS
$18K ﹤0.01%
397
+99
+33% +$4.51K
CRSP icon
1083
CRISPR Therapeutics
CRSP
$4.68B
$18K ﹤0.01%
289
-1,624
-85% -$95.5K
UDMY
1084
DELISTED
Udemy
UDMY
$17K ﹤0.01%
+1,700
New +$20.6K
RARE icon
1085
Ultragenyx Pharmaceutical
RARE
$2.54B
$16K ﹤0.01%
261
+62
+31% +$3.81K
GH icon
1086
Guardant Health
GH
$19.1B
$15K ﹤0.01%
380
+83
+28% +$4.11K
NVAX icon
1087
Novavax
NVAX
$1.22B
$15K ﹤0.01%
291
-3,705
-93% -$192K
ARWR icon
1088
Arrowhead Research
ARWR
$11.8B
$14K ﹤0.01%
394
+89
+29% +$3.35K
BNS icon
1089
Scotiabank
BNS
$108B
$14K ﹤0.01%
235
– –
EWW icon
1090
iShares MSCI Mexico ETF
EWW
$1.92B
$14K ﹤0.01%
300
-200
-40% -$10K
MRVI icon
1091
Maravai LifeSciences
MRVI
$1.02B
$14K ﹤0.01%
490
+106
+28% +$3.36K
KRTX
1092
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$14K ﹤0.01%
111
+25
+29% +$2.87K
MRTX
1093
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$14K ﹤0.01%
207
+46
+29% +$2.92K
TPTX
1094
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$14K ﹤0.01%
185
+41
+28% +$1.82K
CYTK icon
1095
Cytokinetics
CYTK
$10.8B
$13K ﹤0.01%
319
+74
+30% +$2.98K
DNLI icon
1096
Denali Therapeutics
DNLI
$3.78B
$13K ﹤0.01%
458
+102
+29% +$2.67K
VIR icon
1097
Vir Biotechnology
VIR
$1.48B
$13K ﹤0.01%
493
+111
+29% +$2.59K
ABCL icon
1098
AbCellera Biologics
ABCL
$1.63B
$11K ﹤0.01%
1,060
+238
+29% +$2.02K
BPMC
1099
DELISTED
Blueprint Medicines
BPMC
$11K ﹤0.01%
222
+50
+29% +$2.93K
FOLD
1100
DELISTED
Amicus Therapeutics
FOLD
$11K ﹤0.01%
1,044
+231
+28% +$1.9K
42 43
44
45 46

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q2 2022 Portfolio in Review

As of Q2 2022, Daiwa Securities Group held 1,479 positions worth $13.1B, down 18% from $16B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Daiwa Securities Group's Q2 2022 filing shows 56 new, 646 increased, 399 reduced and 58 closed positions. Its largest new stake was HDFC Bank: 143,030 shares worth $3.93M. The largest sale was American Tower, an estimated $263M.

By sector, the portfolio is most concentrated in Real Estate at 61% of assets, up from 60% a quarter earlier, followed by Technology and Healthcare.

  • Daiwa Securities Group's largest Q2 2022 buy was HDFC Bank: 143,030 shares worth $3.93M.
  • Daiwa Securities Group added most to Mid-America Apartment Communities in Q2 2022, an estimated $174M increase.
  • Daiwa Securities Group's biggest Q2 2022 reduction was American Tower, cutting an estimated $263M.
  • Daiwa Securities Group fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $7.68M.
  • Daiwa Securities Group's ten largest holdings make up 38% of its $13.1B portfolio in Q2 2022.
  • Daiwa Securities Group opened 56 new positions and closed 58 in Q2 2022.
  • Daiwa Securities Group's portfolio value fell 18% quarter-over-quarter to $13.1B.

Based on Daiwa Securities Group's 13F filing for Q2 2022, filed 9 Aug 2022.